isoleucyl-prolyl-arginine-4-nitroanilide has been researched along with fibrinopeptide b in 1 studies
| Studies (isoleucyl-prolyl-arginine-4-nitroanilide) | Trials (isoleucyl-prolyl-arginine-4-nitroanilide) | Recent Studies (post-2010) (isoleucyl-prolyl-arginine-4-nitroanilide) | Studies (fibrinopeptide b) | Trials (fibrinopeptide b) | Recent Studies (post-2010) (fibrinopeptide b) |
|---|---|---|---|---|---|
| 23 | 0 | 0 | 445 | 5 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hogg, PJ; Jackson, CM | 1 |
1 other study(ies) available for isoleucyl-prolyl-arginine-4-nitroanilide and fibrinopeptide b
| Article | Year |
|---|---|
Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
Topics: Amino Acid Sequence; Chromogenic Compounds; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Heparin; Humans; Hydrogen-Ion Concentration; Hydrolysis; Macromolecular Substances; Molecular Sequence Data; Oligopeptides; Prothrombin; Substrate Specificity; Thrombin | 1990 |